MANUFACTURERS LIFE INSURANCE COMPANY, THE - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,422,401
+46.9%
20,352
+51.0%
0.00%0.0%
Q2 2023$968,242
+20.5%
13,474
+3.5%
0.00%
Q1 2023$803,259
-19.8%
13,023
+0.3%
0.00%
-100.0%
Q4 2022$1,001,764
+89.8%
12,988
+9.8%
0.00%
Q3 2022$527,899
+16.9%
11,831
+0.3%
0.00%
Q2 2022$451,595
-6.2%
11,791
+1.3%
0.00%
Q1 2022$481,531
-12.1%
11,634
-19.8%
0.00%
Q4 2021$548,000
+11.4%
14,499
-2.8%
0.00%
Q3 2021$492,000
-54.0%
14,913
-6.0%
0.00%
-100.0%
Q2 2021$1,070,000
+19.3%
15,863
+0.2%
0.00%0.0%
Q1 2021$897,000
-34.2%
15,838
-5.4%
0.00%0.0%
Q4 2020$1,364,000
+18.6%
16,737
+3.7%
0.00%0.0%
Q3 2020$1,150,000
-9.3%
16,134
-2.8%
0.00%0.0%
Q2 2020$1,268,000
+26.7%
16,604
-2.4%
0.00%0.0%
Q1 2020$1,001,000
-36.8%
17,021
+11.1%
0.00%
-50.0%
Q4 2019$1,583,000
+362.9%
15,317
-1.2%
0.00%
Q3 2019$342,000
-9.5%
15,496
+5.7%
0.00%
Q2 2019$378,000
+12500.0%
14,662
+2880.1%
0.00%
Q2 2017$3,000
+50.0%
492
-7.7%
0.00%
Q1 2017$2,000
-50.0%
5330.0%0.00%
Q4 2016$4,0000.0%5330.0%0.00%
Q3 2016$4,0000.0%5330.0%0.00%
Q2 2016$4,000
-20.0%
5330.0%0.00%
Q1 2016$5,0005330.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders